Does prophylactic octreotide benefit patients undergoing elective pancreatic resection?

Yeo, C J

Yeo, C J.

J Gastrointest Surg ; 3(3): 223-4, 1999.

Article in En | MEDLINE | ID: mdl-10809581

Subject(s)

Gastrointestinal Agents/therapeutic use; Hormones/therapeutic use; Octreotide/therapeutic use; Pancreatectomy; Premedication; Cost-Benefit Analysis; Economics, Pharmaceutical; Elective Surgical Procedures; Gastrointestinal Agents/economics; Hormones/economics; Humans; Meta-Analysis as Topic; Octreotide/economics; Pancreatectomy/adverse effects; Pancreatectomy/classification; Pancreatic Fistula/prevention & control; Pancreaticoduodenectomy/adverse effects; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatectomy / Premedication / Gastrointestinal Agents / Octreotide / Hormones Type of study: Health_economic_evaluation / Systematic_reviews Limits: Humans Language: En Journal: J Gastrointest Surg Journal subject: GASTROENTEROLOGIA Year: 1999 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links